Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.01% is 71% below its 5-year average of 0.04%, near the low end of its 5-year range (0.00%–0.27%).
As of the fiscal period ended Tuesday, June 30, 2026. 49.43% below its 12-month average of 0.02%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.01%.
DEBT TO ASSETS RATIO
0.01%
DEBT TO ASSETS RATIO AVG TTM
0.02%
DEBT TO ASSETS RATIO AVG 3Y
0.03%
DEBT TO ASSETS RATIO AVG 5Y
0.04%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-49.43%
CURRENT VS 3Y AVG
-55.06%
CURRENT VS 5Y AVG
-71.41%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-87.07%
vs the sector median at left
NewAmsterdam Pharma Company N.V.
Market Cap
$2.53B
Debt to Assets Ratio
0.01%
TTM Avg
0.02%
3Y Avg
0.03%
5Y Avg
0.04%
Market Cap
$2.57B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.46B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.61B
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.41B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.65B
Debt to Assets Ratio
0.71%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.40B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NewAmsterdam Pharma Company N.V. (NAMS) | $2.53B | 0.01% | 0.02% | 0.03% | 0.04% |
| Privia Health Group, Inc. (PRVA)vs › | $2.57B | 0.01% | N/A | N/A | N/A |
| Supernus Pharmaceuticals, Inc. (SUPN)vs › | $2.46B | 0.03% | N/A | N/A | N/A |
| Beam Therapeutics Inc. (BEAM)vs › | $2.61B | 0.18% | N/A | N/A | N/A |
| Neogen Corporation (NEOG)vs › | $2.62B | 0.24% | N/A | N/A | N/A |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.41B | 0.05% | N/A | N/A | N/A |
| Disc Medicine, Inc. (IRON)vs › | $2.41B | 0.08% | N/A | N/A | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.65B | 0.71% | N/A | N/A | N/A |
| Clover Health Investments, Corp. (CLOV)vs › | $2.40B | 0.00% | N/A | N/A | N/A |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.66B | 0.01% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
9.03
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.01% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.03% |
| 2025-09-30 | 0.03% |
| 2025-06-30 | 0.04% |
| 2025-03-31 | 0.05% |
| 2024-12-31 | 0.05% |
| 2024-09-30 | 0.12% |
| 2024-06-30 | 0.13% |
| 2024-03-31 | 0.01% |
| 2023-12-31 | 0.02% |
| 2023-06-30 | 0.02% |
| 2022-12-31 | 0.03% |
| 2022-09-30 | 0.03% |
| 2022-06-30 | 0.07% |
| 2022-03-31 | 0.07% |
| 2021-12-31 | 0.27% |
| 2021-09-30 | 0.27% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 126.21% |
| 2020-06-30 | 126.21% |
| 2020-03-31 | 126.21% |
